MTAP and central nervous system cancer: The expression levels of risk factors IL4I1, SMS, and ADI1 in high-grade gliomas were higher than those in lower‐grade gliomas, while the protein expression levels of protective factor GCLC, MSRB2, MTAP and MPST were exactly the opposite (Fig. S2).